BAK
Braskem S.A.
NYSE · Basic Materials · Chemicals · BR
$1.89
−2.58%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 70.6B | 69.3B | 77.4B | 70.6B | 96.5B |
| Cost of Revenue | 64.3B | 67.8B | 71.4B | 67.5B | 85.2B |
| Gross Profit | 6.3B | 1.5B | 6.0B | 3.0B | 11.4B |
| Operating Expenses | |||||
| R&D Expense | 431.0M | 451.0M | 463.0M | 383.0M | 374.0M |
| SG&A Expense | 4.7B | 4.7B | 4.6B | 4.4B | 4.9B |
| General & Admin Expense | 2.7B | 2.6B | 2.6B | 2.5B | 2.8B |
| Selling & Marketing Expense | 2.0B | 2.1B | 2.0B | 1.9B | 2.1B |
| Other Expenses | (1.8B) | 342.3M | (108.0M) | — | — |
| Total Operating Expenses | 3.3B | 5.5B | 5.0B | 4.8B | 5.2B |
| Cost and Expenses | 67.6B | 73.3B | 76.4B | 72.3B | 90.4B |
| Operating Income (EBIT) | 3.0B | (3.9B) | 1.0B | (1.8B) | 6.1B |
| Non-Operating | |||||
| Interest Income | 311.7M | 711.7M | 1.3B | 1.5B | 1.1B |
| Interest Expense | 4.7B | 5.8B | 5.4B | 4.3B | 3.3B |
| Net Interest Income | (4.4B) | (5.1B) | (4.2B) | (2.8B) | (2.3B) |
| Other Non-Op Income/Expense | (1.6B) | 1.2B | (18.7B) | (4.4B) | (6.1B) |
| Non-Operating Income (excl Interest) | (1.8B) | — | 2.1B | 192.0M | 2.7B |
| EBT (Pre-Tax Income) | 1.4B | (2.8B) | (17.7B) | (6.2B) | 47.0M |
| Income Tax Expense | 8.0B | 8.0B | (5.7B) | (1.3B) | 868.0M |
| Bottom Line | |||||
| Net Income | (5.5B) | (9.7B) | (11.3B) | (4.6B) | (336.0M) |
| Earnings from Cont. Ops | (6.6B) | (10.7B) | (12.1B) | (4.9B) | (821.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (5.5B) | (9.7B) | (11.3B) | (4.6B) | (336.0M) |
| Per Share | |||||
| Basic EPS | ($14.27) | ($24.32) | ($28.40) | ($22.98) | ($2.06) |
| Diluted EPS | ($14.27) | ($24.32) | ($28.40) | ($22.98) | ($2.06) |
| Revenue Per Share | $177.27 | $173.93 | $194.21 | $354.19 | $242.36 |
| Shares | |||||
| Basic Shares Outstanding | 398.3M | 398.6M | 398.6M | 199.2M | 398.2M |
| Diluted Shares Outstanding | 398.3M | 398.6M | 398.6M | 199.2M | 398.6M |
| Profitability Metrics | |||||
| EBITDA | 10.0B | 631.4M | 2.7B | 3.3B | 8.1B |
| D&A | 5.3B | 4.6B | 3.8B | 5.2B | 4.7B |
| EBIT | 4.7B | (3.9B) | (1.1B) | (1.9B) | 3.4B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026